A Multi-Center, Observational Study to Evaluate the Efficacy and Safety of Enavogliflozin in Patients With Type II Diabetes Mellitus Accompanied by Hypertension or Dyslipidemia
Latest Information Update: 06 Nov 2024
At a glance
- Drugs Enavogliflozin (Primary) ; Enavogliflozin (Primary)
- Indications Dyslipidaemias; Hypertension; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Daewoong Pharmaceutical
- 22 Oct 2024 New trial record